Rigel Pharmaceuticals, Inc.
RIGL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $17 | -$25 | -$59 | -$18 |
| Dep. & Amort. | $2 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $12 | $9 | $12 | $9 |
| Change in WC | $0 | $10 | -$29 | $10 |
| Other Non-Cash | -$1 | -$0 | $0 | $3 |
| Operating Cash Flow | $31 | -$6 | -$74 | $6 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$15 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$35 | -$31 | -$29 | -$141 |
| Inv. Sales/Matur. | $40 | $42 | $101 | $62 |
| Other Inv. Act. | $0 | $0 | $1 | $0 |
| Investing Cash Flow | $4 | -$4 | $73 | -$80 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $20 | $20 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$10 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | -$2 | -$13 | $63 |
| Financing Cash Flow | -$12 | $18 | $7 | $63 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $24 | $8 | $6 | -$11 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $33 | $24 | $19 | $30 |
| End Cash | $57 | $33 | $24 | $19 |
| Free Cash Flow | $31 | -$21 | -$74 | $5 |